Xalkori Approved for Advanced Lung Cancer (HealthDay)

08/29/2011 majac Your Health Matters

HealthDay – MONDAY, Aug. 29 (HealthDay News) — Xalkori (crizotinib) and a
companion diagnostic test have been approved by the U.S. Food and Drug
Administration to treat advanced non-small cell lung cancer (NSCLC) with a
certain genetic abnormality, the agency said in a news release.

Share on Facebook

Save

Drug Administration, NSCLC